Skip to main content
. 2013 Jun 24;8(6):e66627. doi: 10.1371/journal.pone.0066627

Table 4. Clinical outcomes at age three years.

Control Bolus Vitamin D RR OR P aOR P
(%) (%) (95% CI) (95% CI) (95% CI)
Wheeze ever 14/50 (28) 15/52 (29) 1.03 (0.56, 1.91) 1.04 (0.44, 2.47) 0.93 1.17 (0.44, 3.10) 0.75
Recurrent wheezing 7/50 (14) 9/52 (17) 1.24 (0.50 (3.07) 1.29 (0.44, 3.77) 0.65 1.91 (0.53, 6.75) 0.31
Wheezing in the last year 8/50 (16) 9/52 (17) 1.08 (0.45, 2.58) 1.10 (0.39, 3.12) 0.86 1.29 (0.40, 4.15) 0.66
Wheeze with positive API 7/50 (14) 9/51 (18) 1.26 (0.51, 3.12) 1.32 (0.45, 3.86) 0.62 2.01 (0.58, 6.99) 0.27
Any bronchodilator use 4/49 (8) 14/48 (29) 3.57 (1.27, 10.09) 4.63 (1.40, 15.34) 0.008* 5.43 (1.39, 21.20) 0.02*
Eczema ever 15/49 (31) 15/48 (31) 1.02 (0.56, 1.85) 1.03 (0.44, 2.44) 0.95 0.86 (0.32, 2.28) 0.76
Eczema in the last year 7/49 (14) 9/48 (19) 1.31 (0.53, 3.24) 1.39 (0.47, 4.08) 0.55 1.97 (0.47, 8.27) 0.36
Atopy 7/27 (26) 7/32 (22) 0.84 (0.34, 2.11) 0.80 (0.24, 2.66) 0.72 0.31 (0.05, 1.83) 0.20
Allergic rhinitis 7/49 (14) 4/46 (9) 0.61 (0.19, 1.94) 0.57 (0.16, 2.10) 0.40 0.91 (0.20, 4.11) 0.90
Food allergy diagnosed 3/49 (6) 4/47 (9) 1.36 (0.32, 5.78) 1.43 (0.30, 6.75) 0.65 1.31 (0.24, 7.18) 0.76
>4 URTI/year 7/50 (14) 9/48 (19) 1.34 (0.54, 3.31) 1.42 (0.48, 4.17) 0.53 1.72 (0.49, 6.04) 0.39
LRTI ever 11/50 (22) 17/47 (36) 1.64 (0.86, 3.14) 2.01 (0.82, 4.92) 0.12 2.87 (1.03, 8.03) 0.05*
Primary health care record
Recurrent wheeze 3/31 (10) 6/34 (18) 1.82 (0.50, 6.68) 2.00 (0.46, 8.80) 0.35 1.85 (0.36, 9.66) 0.47
Eczema 6/31 (19) 5/34 (15) 0.76 (0.26, 2.24) 0.72 (0.20, 2.64) 0.62 0.63 (0.11, 3.59) 0.60
Food allergy 2/31 (7) 0/34 (0) 0.0 (-, -) - - - -

Bolus vitamin D versus control.

RR = Risk Ratio, OR = unadjusted odds ratio, aOR =  adjusted odds ratio, API = Asthma predictive index, URTI = upper respiratory tract infection, LRTI = lower respiratory tract infection.

Model adjusted for mother’s ethnic group, presence of household smokers, maternal smoking in pregnancy, exclusive breast-feeding to four months, any parental allergic history, any child vitamin supplementation, number of children in the household, age mother left full-time education and baseline concentration of 25(OH)D in maternal blood.

*

Adjusted p-value for multiple testing non-significant at 20% level.